News | April 08, 2009

Baylor College of Medicine Uses Carestream Molecular Imaging In-Vivo Technology

April 8, 2009 - Baylor College of Medicine (BCM) is using the latest optical molecular imaging technology from Carestream Molecular Imaging as part of its intensive research efforts involving cancer, cardiovascular disease, infectious agents, inflammatory disease and other conditions.

The company’s KODAK In-Vivo Multispectral Imaging System FX is installed at BCM’s Frensley Center for Imaging Research, which uses imaging to support development of novel agents and other research tools used in the detection and treatment of diseases. Researchers apply the system to a wide variety of imaging techniques that combine optical and x-ray, as well as other modalities such as PET and SPECT isotopes.

“The KODAK Multispectral System combines optical, X-ray, and nuclear imaging, allowing us to more precisely localize the molecular signals in vivo—based on the co-registered multi-imaging modalities,” said Shi Ke, M.D., Technical Director of the Frensley Center for Imaging Research, Baylor College of Medicine. “I believe optical molecular imaging has a bright future, because it will offer more target-specific agents in the light spectrum with accuracy and specificity for disease detection than current PET metabolic agents.”

He continued, “Optical molecular imaging also delivers the ability to simultaneously test multiple disease markers. Since it usually takes 24 to 48 hours to get results from each test, this will greatly speed disease identification and allow treatment to begin more quickly.”

The Frensley Center for Imaging Research is led by Dr. Michel E. Mawad, Chair of the Department of Radiology; and Dr. Wei Wang, who is the chemist responsible for design and synthesis of the agents. The Center emphasizes the combination of chemistry and biology research. The mission of the Frensley Center for Imaging Research is to serve the imaging research interests of the basic science and clinical faculty. It also focuses upon industrial collaboration with key device, drug, and imaging partners to bring imaging and therapy advances to the clinic and benefit patients.

For more information: http://mi.carestreamhealth.com

Related Content

Netherlands Cancer Institute Exploring Molecular Imaging Technology for Prostate Cancer Surgery
News | Molecular Imaging | October 26, 2017
The Netherlands Cancer Institute (NKI) announced it has received funding from the Dutch Cancer Society (KWF...
SNMMI Publishes New FDG PET/CT Appropriate Use Criteria
News | PET-CT | October 25, 2017
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
Toshiba Highlights Latest CT Advancements at RSNA 2017
News | Computed Tomography (CT) | September 18, 2017
Toshiba Medical announced that it will display several new enhancements to its existing computed tomography (CT)...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
FDG-PET/CT Predicts Melanoma Patients' Response to Immune Checkpoint Inhibitor Therapy
News | PET-CT | September 07, 2017
September 7, 2017 — Advanced melanoma has a poor prognosis, but immune checkpoint inhibitor therapy can be effective
Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging | August 18, 2017
August 18, 2017 — The American Society of Nuclear Cardiology (ASNC) has released a joint expert consensus document wi
Overlay Init